Post by
fossi_2002 on Jan 17, 2024 10:00am
rising revenue with no additional capital?
Proph... fossi wants to live in a perpetual fantasy world of rapidly rising revenue with no additional capital required.
If I remember correctly, we have invested tens of millions in our new production facility, with the possibility of tripling our turnover.
What has become of it?
We need a manager who knows how to handle the capital invested.
Gilles is not.
Comment by
prophetoffactz on Jan 17, 2024 10:21am
"What has become of it?" Carolyn Egbert, Chair of Aeterna: “Ceapro has well-established and growing commercial operations, with potential value-creating pipeline opportunities in large and growing cosmetic and consumer health markets. We believe that the new company will have the capital resources to support this ongoing growth"
Comment by
Tencents on Jan 17, 2024 1:06pm
Notably she avoids to mention pharma/neutraceuticals which is in the czo recent press release she however needs to concrete her message 'with potentiel value creating ' is it value creating or not and how much/ when 'we believe the company will have resources' will it have the resources or not and how much /when
Comment by
lscfa on Jan 17, 2024 1:52pm
Where TF you $980,000? Gagnon makes $150k as director at AEZS
Comment by
Ciao on Jan 17, 2024 2:16pm
I mentioned this as the source a while back when I quoted it, and said according to this site; https://ca.wallmine.com/nasdaq/aezs/officer/2071865/gilles-gagnon "As the Director of Aeterna Zentaris, the total compensation of Gilles Gagnon at Aeterna Zentaris is $980,550. There are no executives at Aeterna Zentaris getting paid more."
Comment by
Hopeforthebest on Jan 17, 2024 2:31pm
I believe that Ciao is correct as that is what I have seen, Egbert makes about $177,000 but you can be rest assured that before placed her in the puppet regime that he promised her the sky, a nice 401 k top up and freedom 55 is she plays ball.
Comment by
Tencents on Jan 17, 2024 2:20pm
Exactly she used ´consumer health ´ thereby drifting away from the czo statement which was specific on what segments of the consumer health market so did she think specifying the segments as czo did was not appropriate ( too many to be realistic) a long career in law no doubt thought her that use of too many words can backfire